The apolipoprotein E knockout (EKO) mouse is a well-established model of atherosclerosis.
Introduction
Apolipoprotein E (apoE) is a 34 kD glycoprotein which is a component of all lipoprotein particles with the exception of low density lipoprotein (LDL) 1 . It is a ligand for the clearance of chylomicrons and intermediate density lipoprotein particles (IDL) from the circulation via the low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR) and low density lipoprotein related protein 1(LRP1) 2 . Apolipoprotein E knockout (EKO) mice have dramatic elevations of plasma cholesterol (5 fold normal) and reduced high density lipoprotein (HDL) concentrations 3, 4 . These findings mimic those of human patients with Type III hyperlipoproteinemia, which results in increased plasma triglyceride (TG) and cholesterol and premature atherosclerosis.
Apoe is highly expressed in the liver, adipose tissue, macrophages, and other tissues of humans and mice. In adipocytes, apoE expression is increased by PPARγ agonists and decreased by TNF-α 5 . Multiple recent studies have documented protection of the EKO mouse from diet induced obesity (DIO) and insulin resistance [6] [7] [8] [9] . Whole body deficiency of apoE also prevents weight gain and insulin resistance in genetic models of obesity such as the ob/ob or Ay/+ mouse 7, 9, 10 . Protection from diet induced obesity can be reversed by adenoviral over expression of apoE in the liver, suggesting an important role for circulating apoE in adipose tissue lipid uptake 7 .
On the other hand, endogenous adipocyte apoE expression is required for the uptake and storage of free fatty acids. For example, primary adipocytes from EKO mice cultured in vitro synthesize less triglyceride (TG) than WT when incubated with VLDL 11 . Furthermore, EKO adipocytes transplanted into WT mice fail to increase in size in response to 10 weeks of HFD 11 .
There are at least two mechanisms by which absence of apoE impairs TG synthesis in adipocytes 2, 11 . Binding and whole particle uptake of VLDL to EKO adipocytes is impaired due to reduced expression and/or decreased cell surface localization of VLDLR, LDLR, and LRP1 11 .
Lipoprotein lipase (LPL) dependent TG synthesis is also decreased in EKO adipocytes. This is thought to be due impaired fatty acid translocation across lipid rafts, as caveolin 1 expression is markedly reduced in EKO adipocytes 11 . These same mechanisms may also account for reduced lipid uptake in liver and skeletal muscle, protection from lipotoxicity, and preservation of whole body insulin sensitivity despite severe hyperlipidemia 2, 12 .
Macrophage uptake of triglyceride rich lipoproteins (TRLP), unlike adipocytes, is not dependent on apoE. Foam cells take up modified lipoproteins via scavenger receptors, predominantly SRA and CD36 13 . Rather, apoE in macrophages is important in reverse cholesterol transport and lipidation of ApoA1 and HDL by cholesterol export via ABCA1 and ABCG1 14 . Two studies have shown that bone marrow transplantation of apoE +/+ macrophages into EKO mice ameliorates atherosclerosis; this is accompanied by improvements in serum lipoprotein profiles to wild type levels 15, 16 . Therefore, in contrast to adipocytes and other tissues, macrophage specific apoE appears to serve a protective effect in respect to lipid handling 14 . This serves to distinguish the role of the macrophage in atherosclerosis from its role in diet induced obesity, the depletion of which, improves metabolic disease. The specific lipid moieties that stimulate foam cell formation in each case might account for these differences.
While it is well established that modified lipoprotein particles are the stimulus for foam cell formation in atherosclerosis, it has only recently been suggested that free fatty acids may be responsible for foam cell formation in circumstances of increased adipocyte lipolysis, such as obesity or fasting 17 .
Interestingly, adipocytes from EKO mice have been shown to have increased rates of lipolysis in vitro, thus we would expect greater inflammation in the VAT from these mice 5 .
Therefore, the purpose of this study was to determine 1) how does adipocyte gene expression change in response to HFD the absence of endogenous adipocyte apoE? and 2) is the visceral adipose tissue of EKO mice characterized by increased foam cell accumulation analogous to the atherosclerotic plaque?
Materials and Methods

Animal Studies
An original colony Apoe -/-(Apoe tm1Un ) on the C57BL6/J background was purchased from the Animals were weighed weekly for the duration of the diet study. Intraperitoneal glucose tolerance testing was performed as previously described 18 . Area under the curve for the GTT was calculated using the trapezoidal method . At the completion of HFD, mice were fasted for 4
hours and then euthanized with CO2 inhalation and bilateral pneumothorax. Livers and epididymal VAT were then harvested and snap frozen in liquid nitrogen. All experiments were performed in accordance with protocols approved by the Animal Care and Use Committee at UMASS Medical School.
Metabolic Phenotyping
Body composition was determined non-invasively in awake mice using 1 H-MRS (Echo Medical System). For metabolic studies, mice were housed under controlled temperature and lighting with free access to food and water. The food/water intake, energy expenditure, respiratory exchange ratio, and physical activity were performed on three consecutive days using metabolic cages (TSE Systems). Post prandial oxygen consumption was calculated by subtracting the pre-fed VO2 (ml/hr)(16:00) from the post-fed (VO2)(6:00) as previously described 19 . 
Free Fatty
Histology and Immunohistochemistry
Adipose tissue samples (n=3 per group) from normal and high fat diet animals were fixed in 4% formalin for immunohistochemistry. Briefly, samples were embedded in paraffin, sectioned, and stained with a rat anti-mouse F4/80 (ABd Serotec, Raleigh, NC)(1:40 dilution). Staining was visualized with a HRP linked rabbit anti-rat secondary anti-body. Staining with the secondary antibody alone was performed as a negative control. Images were taken with a Zeiss Microscope and PixeLINK SE Software.
Statistical Analysis
All values are shown as mean ± SEM. For experiments other than the microarray analyses, the Student's t test for two tailed distributions with equal variances was used for comparison between 2 groups; for comparisons greater of ≥ 3 groups, two way ANOVA followed by the Bonferroni correction was used. Differences less than p < 0.05 were considered significant.
Data was entered into Microsoft Excel and statistical analyses were performed with Graph Pad Prism 5.
Results
EKO mice are resistant to DIO after 24 and 38 weeks of HFD
Male WT and EKO mice were started on normal diet (ND) or HFD at 8 weeks of age (n=5-6 per group). After 24 weeks, wild type HFD mice were significantly more obese than their ND littermates (48.0 ± 1.6 vs. 33.0 ± 0.8 gms, p<0.001)( Figure 1A ). In contrast, there was no difference between ND and HFD fed EKO mice (34.9 ± 0.5 vs. 34.8 ± 1.1 gms, p=NS). Body composition analyses of mice at 24 weeks of HFD revealed a fivefold increase in fat mass of WT mice, whereas HFD EKO mice had a non significant doubling of fat mass (Table 1 ). Diet and genotype had no influence on lean body mass ( Table 1) .
Fasting plasma glucose was significantly lower in HFD EKO than HFD WT controls and free fatty acids were significantly higher ( Table 1 ). Intraperitoneal GTT revealed that HFD WT mice had impaired glucose tolerance compared to their ND controls at all time points (p<0.05)( Figure   1C ). In contrast, there was no significant difference in glucose tolerance between ND and HFD fed EKO mice.
In a second cohort of animals, we decided to extend the duration of HFD to determine if age related impairments in insulin sensitivity might influence fat accumulation in EKO mice.
Surprisingly, even after 38 weeks of HFD, there was no difference in weight between ND and HFD fed EKO mice (32.4 ± 0.44 vs. 30.20 ± 0.54, p=NS), nor were there differences in glucose tolerance as seen by IP GTT (Fig 1D, F) .
In summary, 24 and 38 weeks of a diet high in saturated fat and cholesterol results in obesity and diabetes in WT but not EKO mice. Increased body mass is due to a five-fold increase in fat mass of HFD fed WT mice. This is consistent with prior studies and extends these data to high fat feeding of chronic duration.
Metabolic cage studies reveal no differences in energy expenditure, food intake, or physical activity
We hypothesized that EKO mice might have increased energy expenditure or decreased food intake which would account for failure to increase their fat mass with high fat feeding.
Metabolic cage analyses were performed for 3 consecutive days after mice had been fed HFD for 23 weeks. There were no differences in food intake or physical activity between genotypes;
HFD mice tended to eat less than their normal chow controls (Table 1) . Likewise, there were no differences in 24 hour energy expenditure rates (Table 1 ).
EKO Mice have increased post-prandial VO2
EKO HFD fed mice had significantly greater rates of normalized VO2 over a 24 hour period than WT HFD fed mice (3804 ± 294 vs. 3073 ± 24 ml/hr/kg, p<0.05)( Table 1 )( Figure 2A ).
Increased rates of VO2 in EKO mice were present in both the light and dark phases. However, when non-normalized VO2 rates were compared, there was no genotype effect, but there was an effect of HFD to increase VO2 (ml/hr)( Figure 2B ) (Table 1 ). ANCOVA confirmed that there was no statistically significant relationship between genotype and VO2 or EE ( As it has been shown that EKO mice have a prolonged clearance time of dietary TG, we hypothesized that they might have an increased post-prandial VO2 consumption. Indeed, the difference between pre-prandial (16:00 hours) and post-prandial (6:00 hours) VO2 (ml/hr/kg) was significantly greater in EKO HFD than WT mice on both diets (p<0.05)( Figure 2C ). This effect remained significant when non-normalized VO2 (ml/hr) was used ( Figure 2D ).
EKO mice are protected against hepatic steatosis induced by 24 weeks of HFD
Although it is well known that EKO mice have severe elevations of blood cholesterol and TG, given that they have greater rates of VO2 (ml/hr) in the post-prandial period, we hypothesized that they may be consuming some fraction of this excess fatty acid via hepatic β oxidation.
Light microscopy showed that HFD EKO mice were protected from hepatic steatosis, while HFD fed WT mice had severe hepatosteatosis with hepatocyte ballooning and large lipid droplet formation ( Figure 3B ). Indeed, WT HFD mice had a 5 fold increase in liver triglyceride concentrations compared to WT ND mice, whereas EKO HFD had no such increase in liver triglyceride in comparison to their ND controls ( Figure 3E ). Finally, mRNA expression of the lipid droplet protein genes Cidea and Fsp27 was increased 1000 and 100 fold respectively in WT HFD fed mice (p<0.05)( Figure 3F ).
Although liver TG concentrations were significantly lower in HFD fed EKO mice, serum free fatty acids were greater in ND and HFD fed EKO mice (Table 1) . Serum β hydroxybutyrate concentrations were also 5 fold higher in EKO HFD than WT HFD mice (4.9 ± 0.56 vs. 0.83 ± 0.24 mM, p<0.001)( Table 1 ). This supported our hypothesis that decreased fat storage in EKO adipose tissue results in increased delivery of fatty acids to the liver, which may be used as substrate for β oxidation and ketone formation.
Comparative insensitivity of EKO VAT gene expression in response to HFD
Given that EKO mice have an impaired ability to uptake and store dietary fat as triglyceride,
we hypothesized that EKO adipocytes might compensate by stimulating de novo lipogenesis.
Increased glucose uptake by adipose tissue would allow for this and partially explain the improved glucose tolerance of EKO mice. Therefore, we queried expression of key transcription factors (Srebf1, Nr1h3/Lxrα) and regulatory enzymes (Acly, Fasn) which regulate de novo lipogenesis using qPCR. We were surprised to find that obese HFD WT mice had significantly increased expression of Fasn (3.3 fold) , Acly (4.3 fold), Srebf1 (3.0 fold), and Dgat2 (5.9 fold)
while HFD EKO mice had no such increase (Figure 4) . In comparison to ND controls, HFD fed EKO mice had a decrease in expression of all these genes, two of which were statistically significant (Lxrα/Nr1h3 0.44 fold, Dgat2 0.33 fold) (Figure 4 ).
To gain a more comprehensive picture of these changes in gene expression, we performed whole genome expression profiling of VAT from WT and EKO mice fed ND and HFD for 24
weeks. Using the Affymetrix Mouse Gene 1.0 ST chip, we performed 4 biological replicates per condition. We defined differential expression as a fold change >1.5 at an alpha of p<0.05.
When comparing ND WT to HFD WT adipose tissue, expression of 880 genes was significantly different between conditions (3% of represented probes)( Figure 5 , Supp. Table 1 ). In contrast to WT VAT, EKO VAT was remarkably insensitive to dietary fat in terms of quantitative changes in gene expression. Expression of only 53 genes was differentially regulated in EKO adipose tissue when comparing ND versus HFD (0.1% of represented probes)( Figure 5 , Supp. Table 1 ).
Gene set enrichment analysis (GSEA) revealed that the top ten molecular pathways represented in the over expressed genes in WT HFD mice were all inflammatory signaling nodes ( Figure 5 ). Interestingly, the pathway with the greatest fold enrichment in the EKO HFD fed mice was the peroxisome proliferator activated receptor alpha (PPARα) pathway; less than half of the remaining pathways represented in the EKO HFD mice were inflammatory pathways ( Figure 5 ).
We then specifically queried expression of an a priori list of genes whose products encode proteins which function in fatty acid metabolism, including PPARγ target genes, proadipogenesis genes, β oxidation genes, and cholesterol metabolism genes ( uniformly and significantly down regulated in response to HFD in WT mice (p<0.05)( Table 3 ). In contrast, PPARγ target genes were not significantly down-regulated in EKO adipose tissue.
Interestingly, genes belonging to cholesterol metabolism pathways were significantly upregulated in the HFD fed WT mice, whereas there was no response to HFD in EKO adipose tissue. The only gene set consistently up-regulated in HFD fed EKO mice were those encoding enzymes responsible for fatty acid catabolism and β oxidation ( Table 3 ). These findings corroborated the GSEA, which showed increased expression of genes in the PPARα signaling pathway ( Figure 5 ).
Reduced F480 staining and Macrophage Specific Gene Expression EKO HFD VAT
Considering the dramatic increase in expression of inflammatory genes in the WT HFD VAT ( Figure 5 , Supp. Table 1 ) we decided to confirm the extent of macrophage infiltration with HFD by immuno-histochemistry for the macrophage marker F480+ ( Figure 6 ). WT HFD VAT had abundant macrophage F480+ staining, with most appearing as large multi-nucleate cells in crown like structures (CLS)( Figure 6B ). In contrast, there were very few F480+ macrophages or CLS in the EKO HFD VAT ( Figure 6D ). We then queried our microarray analysis for expression of genes known to be enriched in macrophages and immune cells ( Figure 6E ). WT HFD mice had a significant increase in expression of the macrophage specific genes Emr1 (2 fold), Cd68
(3 fold), and Itgax (5 fold), whereas there was no increase in EKO HFD fed mice ( Figure 6E ).
Finally, we validated expression of immune specific genes shown to be up-regulated in the VAT of WT HFD mice on our microarrays using RT-qPCR ( Figure 6F ). Expression of the macrophage specific genes Emr1, Cd68, and Itgax were 8, 10, and 40 fold increased in the WT HFD VAT compared to WT ND mice (p<0.05). In contrast, there was no increase in expression in the HFD fed EKO mice. Expression of Ccl2, IL7r, and Tnfα was also significantly increased in the WT HFD VAT (p<0.05) ( Figure 6F ).
Discussion
It is now well established that the EKO mouse is resistant to DIO and remains glucose tolerant when compared to WT HFD fed controls 6-8, 10, 23, 24 . Our results confirm these prior studies and make three novel contributions: 1) post-prandial VO2 (ml/hr) is increased in HFD fed EKO mice, 2) serum β -hydroxybutyrate concentrations are increased in EKO mice, and 3)
the VAT of EKO mice is comparatively insensitive to HFD in terms of global alterations in gene expression.
Regarding our studies of whole body metabolism, compared to WT controls, EKO mice had a significantly reduced fat mass in response to HFD; this was apparent within 8 weeks of starting a HFD, and continued until 24 and 38 weeks (Supplemental Fig 1) . WT mice had a 5
fold increase in fat mass after 24 weeks HFD while EKO mice had only a 2 fold increase ( Table   1 ). Huang et al. have shown that endogenous adipocyte apoE is required for both LPL dependent and VLDR endocytic uptake of triglyceride rich lipoprotein particles, and this would account for reduced fat mass 11 . However, how do we account for the apparent caloric imbalance in EKO mice?
We detected no differences in food intake or physical activity between WT and EKO animals ( Figure 2A ). However, when we analyzed raw or non-normalized VO2 (ml/hr), there was no significant difference between groups (Table 1, Figure 2B ). ANCOVA revealed that diet, but not genotype, was significantly associated with VO2 (ml/hr) and EE (kcal/hr). The linear model incorporated weight, lean body mass, and fat mass as covariates to account for these independent variables ( Table 2 ). Our use of non-normalized measures of energy expenditure and ANCOVA are in conformity with a recent consensus statement by an expert panel of scientists 26 . It is likely that prior studies which included body weight in the estimation of VO2 (ml/hr/kg) and EE (kcal/hr/kg) erroneously ascribed a greater energy expenditure to EKO mice. Despite these issues, we did find that nonnormalized post-prandial VO2 (ml/hr) was significantly greater in HFD EKO mice than HFD WT mice, a factor which, over the life of the animal, may contribute to reduced weight gain ( Figure   2C ,D) 27 .
Consistent with prior reports, we found that the livers of HFD fed EKO mice were resistant to hepatosteatosis ( Figure 3 ) 6, 7, 24, 25 . As apoE is a ligand for the LDL, VLDL, and remnant receptor (LRP1), the liver cannot take up chylomicron remnants and LDL and therefore may be less prone to lipotoxicity. This highlights the important contribution of dietary fat to hepatic steatosis. However, as VLDL secretion is also dependent upon apoE, and rates of hepatic VLDL secretion are decreased in EKO mice, one might expect hepatic TG to accumulate despite reduced uptake 28, 29 . We observed the exact opposite, that EKO mice were protected from hepatosteatosis with HFD. Increased hepatic β -oxidation of fatty acids may reduce liver TG accumulation in EKO mice 25 . The increased plasma β -hydroxybutyrate concentrations that we observed in ND and HFD EKO mice are consistent with this idea (Table 1) .
Perhaps the most dramatic findings of our study stem from the microarray analyses. ( Figure   5 , Table 3 , & Supp. Tables 1) HFD feeding in EKO mice resulted in significantly altered expression of only 0.1% of probe sets; in contrast, WT HFD mice had a 30 fold greater number of genes whose expression was altered in response to HFD (3%). We initially hypothesized that EKO adipocytes may compensate for decreased TG uptake by increasing de novo fatty acid synthesis. qPCR showed that genes encoding lipogenic enzymes (Acly, Fasn, Dgat) were upregulated in WT HFD adipocytes but not in EKO adipocytes (Fig 4) . We then queried the microarray data for an a priori determined list of genes involved in fatty acid metabolism. We again failed to detect an increase in expression of the same lipogenic genes in EKO adipocytes.
However, we did find some interesting patterns of expression which correlated with our metabolic studies (Table 3) .
First, important PPARγ target genes such as Adipoq, Cfd, Irs1 and Glut4/Slc2a4, were all down regulated in response to HFD in WT VAT; this correlated with the potent inflammatory response in this tissue and impaired whole body glucose metabolism (Table 3) . Inflammation, specifically TNFα, is thought to reduce PPARγ activity in adipocytes 30 . Second, a panel of genes encoding proteins in the cholesterol biosynthesis pathway (Hmgcs1, Insig1, Lss, Hsd17b7) was up regulated in WT HFD fed VAT (Table 3 ). It has been shown in previous studies that large adipocytes are cholesterol deficient due to their requirement for a large plasma membrane, therefore they activate expression of genes to increase cellular cholesterol 31 . In that regard, it is also notable that the expression of the VLDL (1.4 fold, p<0.05) and LDL (1.8 fold, p=NS) receptors was increased (1.4 fold) in the WT HFD mice, likely as an additional mechanism to increase cellular cholesterol (Supp Table 1 ). Cholesterol deficiency causes cellular insulin resistance by reducing signaling through caveolin 2 enriched lipid rafts 31 . Of note, the diameter of WT type adipocytes was much greater than EKO adipocytes at baseline and especially with HFD ( Fig 6) .
In regards to the increased numbers of macrophages in the WT HFD VAT, the microarray data indicate that multiple mechanisms of macrophage lipid uptake appear to be activated, all of which parallel foam cell formation in the atherosclerotic plaque. For example, enzymatically modified LDL particles are internalized mainly by type 1 (opsonin) and type 2 (complement) mediated phagocytosis 32 . Expression of both Cd16/Fcgr3, which binds C reactive protein and IgG coated LDL particles, and Cd11b, which binds complement coated LDL particles, is increased in WT HFD VAT (1.48 and 1.71 fold respectively p<0.05, Suppl. Table 1 ). Type 1 and type 2 phagocytosis lead to the formation of large, membrane associated lipid droplets 32 . In contrast, expression of the macrophage scavenger receptor Msr1, which is responsible for receptor mediated of predominately oxidized LDL particles, is also increased (1.92 fold, p<0.05, Suppl. Table 1) . Expression of these genes is not altered in EKO VAT with HFD. We do not suggest that modified and oxidized LDL are necessarily the ligands for macrophages in adipose tissue, only that it is likely that there are multiple complex lipid antigens released from dying (or viable) adipocytes in WT HFD VAT which broadly stimulate the innate immune response. The decreased cell size of EKO HFD adipocytes may prevent cellular stress and death thus preventing this inflammatory response.
That we do not see increased macrophages in the VAT of HFD EKO mice is not inconsistent with the results of others who have shown that 1) primary EKO adipocytes have increased rates of lipolysis ex vivo and 2) FFA release is a stimulus for macrophage infiltration 5, 17 . On a cellular basis, because the lipolytic rate depends on cell surface area (4πr2), and EKO adipocytes are almost ½ the diameter of WT adipocytes, FFA release per cell is actually likely much smaller in EKO adipocytes. Second, rates of lipid oxidation may be increased in EKO adipocytes, resulting in less release of FFA from hydrolyzed TG. Finally, macrophage infiltration in response to lipolysis has been shown in obese animals subjected to fasting, thus, in negative energy balance, which was not the case for EKO mice 17 .
In regard to changes in gene expression in EKO adipose tissue, expression of genes encoding enzymes important for fatty acid oxidation were broadly up-regulated, for example, Oxpat/Plin5, Cox8b, Acsl5, Acox1, and Acadl ( Table 3 ). Many of the same genes were down regulated in WT HFD VAT. Interestingly, the gene with the highest fold increase in expression in EKO HFD VAT, lactase-like (Lctl), is a recently described member of the fibroblast growth factor family which is specifically expressed only in brown adipose tissue 33 ( Supplemental Table   1 ). Overall, these findings correlated with the results of GSEA, in which the PPARα signaling family was top represented pathway in EKO HFD fed mice ( Figure 5 ). Whether or not fatty acid oxidation is actually functionally increased in EKO adipocytes, and relates to their decreased cell size, will require further study.
In summary, using a combination of physiologic studies, genomics, and immunohistochemistry, we describe novel features of adipocyte metabolism in EKO mice which will provide a starting point for future studies. We confirmed the observation that, despite severe hyperlipidemia, EKO mice fed a HFD are leaner and insulin sensitive than their WT littermates.
This may be due to failure of adipose, skeletal muscle, and liver to properly metabolize circulating triglyceride rich lipoproteins. Second, using careful statistical analysis of metabolic cage data in accordance with expert guidelines, we show that post-prandial VO2 (ml/hr), but not total VO2 or EE is increased in EKO mice. This may partially account for their lean phenotype.
Finally, using the first whole genome comparison of gene expression of WT and EKO adipose tissue, we show that EKO mice have decreased expression of inflammatory genes, and increased expression of genes encoding enzymes responsible for lipid oxidation. These results suggest that limiting adipocyte size or TG uptake may be a viable therapeutic strategy, provided that peripheral mechanisms to prevent atherogenic hyperlipidemia can be activated. GSEA showed that the top ten most enriched pathways in WT HFD mice were all involved in inflammatory pathways (top box). In contrast, the most highly represented pathway in EKO HFD mice was the PPARα signaling family (bottom box). β hydroxybutyrate (mM) 0.36 ± 0.08 0.83 ± 0.24 3.0 ± 0.24 4.9 ± 0.56 † ***p<0.001 vs. WT ND using the Student's t-test, *p<0.05, **p<0.01 vs. WT HFD using two way ANOVA and the Bonferroni correction † † † p<0.001 vs. ND within genotype using two way ANOVA and the Bonferroni correction ^^^p<0.001 vs. WT ND, HFD using two way ANOVA and the Bonferroni correction. † p<0.001 vs. EKO ND using two way ANOVA and the Bonferroni correction. 
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